The Benefits of Topical CBD

The Benefits of Topical CBD

By Claudia le Feuvre
Jump To...

    There’s more than a few ways to enjoy CBD!

    In addition to oral drops, you can also nourish your body by applying CBD through your skin. Taking CBD through the skin is known as transdermal assimilation, and can have a few perks beyond just taking drops alone.

    Here’s how it works.

    The Endocannabinoid System (ECS) & The Skin

    Both the dermis and the epidermis (layers of skin) are home to cannabinoid receptors (CB1 & CB2).

    Typically, the body’s ECS naturally maintains skin health, inflammation, pain, sensitivity and blood flow through these receptors.

    Figure 1. ECS in the skin – Bíró et al., 2009 Trends in pharmacological sciences

    However, sometimes the ECS can become disrupted and fail to arrest pain, inflammation and skin damage. 

    That’s where CBD comes in; it helps support an ECS thats disrupted, by modifying the activity of CB receptors.

    Since CBD can help support the bodies endocannabinoid system, it may benefit many aspects of skin and bodily health indirectly.

    Oral CBD Vs Topical CBD

    CBD is usually taken orally, but can also be applied to the skin, as a massage oil. 

    It doesn’t have the same widespread effects as when its taken orally, since it doesn’t enter the bloodstream.

    The advantages 

    • CBD is more bioavailable when applied through the skin. (bypasses liver)
    • The effects are highly concentrated to the area it is applied.

    The disadvantages

    • The effects of CBD are localised to the area it is applied on the body. 
    • It may not pose the same benefits on the brain and psychological conditions. At least not directly.

    Benefits of a Massage

    A massage can be very therapeutic, and studies show that massages can be helpful for:

    Add CBD into the mix, and the effects seen from massage may be complemented and compounded. Most people who receive a CBD massage say they feel more relaxed, at ease and rested after a treatment.

    Cannablissful Massage Oils

    Cannablissful massage oils combine broad spectrum CBD from hemp with a wide array of aromatic and therapeutic essential oils. 

    Together Cannablissful massage oils provide a powerful synergy in combination with massage to soothe, energise and relax. 

    Soothe: Bring your body into balance with laid back lavender, geranium, bergamot & broad spectrum hemp. 

    Energise: Naturally awaken your energy with lively lemon, peppermint, eucalyptus, lavender & broad spectrum hemp.

    Relax: Restore and renew with kick back chamomile, lavender, jasmine & broad spectrum hemp.

    Cannablissful products are tested to ensure they contain less than 0.2% THC. 

    They are also tested to ensure they contain the CBD they claim to. 

    A massage oil can either be used for a specific bodily part, or the whole body. 

    Whole body massages will require more oil, and may not provide the same degree of pain relief as the same dose applied to a specific area. 

    • Shake well before use, apply 5ml to clean palms to warm and activate the oil.
    • Spread across the body, or to a specific area if desired. 
    • Apply more if needed. 
    • Wait 15-45 minutes for effects to sink in.

    Cannablissful Massage Balm

    Massage balms provide a stronger grip, and lower glide than massage oils. They are ideal for treating specific areas of the body, since they can be applied with more control and precision. 

    Cannablissful massage balm has been designed to provide concentrated CBD and essential oils for targeted massages. 

    External CBD Caveats 

    Some people have found that they can be allergic to the cannabis plant. It’s worth remembering this when you use topical formulations, just in case.

    Although topical CBD may help with wound healing, there is a risk of infection if it is applied to open wounds. Avoid applying CBD until the wound has undergone some healing first.


    Andre, C. M., Hausman, J.-F. and Guerriero, G. (2016) ‘Cannabis sativa: The Plant of the Thousand and One Molecules’, Frontiers in Plant Science. Frontiers Media SA, 7, p. 19. doi: 10.3389/FPLS.2016.00019.

    Bíró, T., Tóth, B. I., Haskó, G., Paus, R., & Pacher, P. (2009). The endocannabinoid system 

    of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends in pharmacological sciences30(8), 411–420.

    Chelliah, M. P. et al. (2018) ‘Self-initiated use of topical cannabidiol oil for epidermolysis bullosa’, Pediatric Dermatology, 35(4), pp. e224–e227. doi: 10.1111/pde.13545.

    Corroon, J. and Phillips, J. A. (2018) ‘A Cross-Sectional Study of Cannabidiol Users.’, Cannabis and cannabinoid research. Mary Ann Liebert, Inc., 3(1), pp. 152–161. doi: 10.1089/can.2018.0006.

    Eagleston, L. R. M. et al. (2018) ‘Cannabinoids in dermatology: a scoping review.’, Dermatology online journal, 24(6). Available at: (Accessed: 2 October 2019).

    Hacke, A. C. M. et al. (2019) ‘Probing the antioxidant activity of Δ9-tetrahydrocannabinol and cannabidiol in Cannabis sativa extracts.’, The Analyst, 144(16), pp. 4952–4961. doi: 10.1039/c9an00890j.

    Hammell, D. C. et al. (2016) ‘Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis’, European journal of pain (London, England). NIH Public Access, 20(6), p. 936. doi: 10.1002/EJP.818.

    Jadoon, K. A., Tan, G. D. and O’Sullivan, S. E. (2017) ‘A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study’, JCI Insight, 2(12). doi: 10.1172/jci.insight.93760.

    Lodzki, M. et al. (2003) ‘Cannabidiol—transdermal delivery and anti-inflammatory effect in a murine model’, Journal of Controlled Release, 93(3), pp. 377–387. doi: 10.1016/j.jconrel.2003.09.001.

    Pellati, F. et al. (2018) ‘Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer’, BioMed Research International, 2018, pp. 1–15. doi: 10.1155/2018/1691428.

    Whiting, P. F. et al. (2015) ‘Cannabinoids for Medical Use’, JAMA, 313(24), p. 2456. doi: 10.1001/jama.2015.6358.

    Wilkinson, J. D. and Williamson, E. M. (2007) ‘Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis’, Journal of Dermatological Science, 45(2), pp. 87–92. doi: 10.1016/j.jdermsci.2006.10.009.


    Leave a Reply

    Your email address will not be published. Required fields are marked *

    Search Star Arrow right Phone Pin email arrow-next arrow-prev Account Cart
    Facebook Instagram Twitter Tumblr YouTube Pinterest Pinterest Soundcloud Behance Google Plus LinkedIn Search Email Tik Tok